XML 39 R25.htm IDEA: XBRL DOCUMENT v3.19.2
5. Benefit Plans (Tables)
12 Months Ended
Apr. 30, 2019
Schedule of stock option activity

   Stock Options  

Grant Date

Weighted

Average Exercise

Price

  

Weighted

Average

Remaining

Contractual

Life (in years)

  

Aggregate

Intrinsic

Value (1)

 
Outstanding at May 1, 2018   3,597,738   $8.74           
Granted   973,614   $5.00           
Exercised   (371,327)  $3.45           
Canceled or expired   (925,810)  $11.28           
Outstanding at April 30, 2019   3,274,215   $7.51    5.53   $1,238 
Vested and expected to vest   3,274,215   $7.51    5.53   $1,238 
Exercisable at April 30, 2019   1,932,527   $9.45    3.87   $700 

______________

(1)Aggregate intrinsic value represents the difference between the exercise price of an option and the closing market price of our common stock on April 30, 2019, which was $4.79 per share.

 

Schedule of RSU activity
    Shares  

Weighted Average

Grant Date

Fair Value

 
 Outstanding at May 1, 2018       $ 
 Granted    217,200    4.28 
 Vested         
 Forfeited    (16,825)   3.78 
 Outstanding at April 30, 2019    200,375   $4.32 
Share-based compensation expense
   Fiscal Year Ended April 30, 
   2019   2018   2017 
Cost of revenues  $474   $378   $108 
Selling, general and administrative expense   1,121    820    1,553 
Discontinued operations
       340    1,702 
   Total  $1,595   $1,538   $3,363 
Equity Option [Member]  
Fair value valuation assumptions
   Fiscal Year Ended April 30, 
   2019   2018   2017 
Risk-free interest rate   2.81%    2.21%    1.32% 
Expected life (in years)   5.57    6.19    6.12 
Expected volatility   76.56%    110.43%    111.30% 
Expected dividend yield            
Employee Stock Purchase Plan [Member]  
Fair value valuation assumptions
   Fiscal Year Ended April 30, 
   2019   2018   2017 
Risk-free interest rate   2.26%    1.10%    0.46% 
Expected life (in years)   0.50    0.50    0.50 
Expected volatility   71.10%    75.18%    105.27% 
Expected dividend yield